Edgewood Oncology
About:
Edgewood Oncology is promoting a first-in-class therapy for malignancies that are challenging to treat.
Website: https://www.edgewoodoncology.com/
Top Investors: Alta Partners
Description:
Edgewood Oncology is a clinical-stage biotechnology business established to fulfill the potential of BTX-A51 for patients with solid tumors that are genetically specified and hematologic malignancies. Our goal is to create a novel treatment that will prolong and enhance the lives of those with the greatest unmet medical needs.
Total Funding Amount:
$20M
Headquarters Location:
Brookline, Massachusetts, United States
Founded Date:
2023-01-01
Contact Email:
info(AT)edgewoodonc.com
Founders:
David N. Cook
Number of Employees:
1-10
Last Funding Date:
2024-03-25
IPO Status:
Private
Industries:
© 2025 bioDAO.ai